APA (7th ed.) Citation

Blumenfeld, A. M., Stark, R. J., Freeman, M. C., Orejudos, A., & Adams, A. M. (2018, February). Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study. The Journal of Headache and Pain.

Chicago Style (17th ed.) Citation

Blumenfeld, Andrew M., Richard J. Stark, Marshall C. Freeman, Amelia Orejudos, and Aubrey Manack Adams. "Long-term Study of the Efficacy and Safety of OnabotulinumtoxinA for the Prevention of Chronic Migraine: COMPEL Study." The Journal of Headache and Pain Feb. 2018.

MLA (9th ed.) Citation

Blumenfeld, Andrew M., et al. "Long-term Study of the Efficacy and Safety of OnabotulinumtoxinA for the Prevention of Chronic Migraine: COMPEL Study." The Journal of Headache and Pain, Feb. 2018.